Skip to Content

Uniphar/LXV Remedies (Sam McCauley)

M/22/049

Completed

Transaction details

The proposed acquisition by Uniphar plc, through its wholly-owned subsidiary Trennamally Limited, of LXV Remedies Holdings Limited has been cleared by the Competition and Consumer Protection Commission subject to a number of legally binding commitments.
Case details
  • Notification date:18 September 2022
  • Publication date:18 September 2022
  • Economic sector:Wholesale & retail trade - G
  • Economic sub-sector:Retail trade - G.47
  • Request for information:Yes
  • Outcome:Cleared with proposals
Documents
M.22.049 DeterminationPDF | 785 KB
Timetable

Phase One

  • Monday, 19 September, 2022 Notification received
  • Tuesday, 4 October, 2022 Third party submission deadline
  • Thursday, 27 October, 2022 Further information required
  • Monday, 21 November, 2022 Further information received
  • Thursday, 20 January, 2022 Proposals received
  • Thursday, 20 January, 2022 Determination issued
Parties Involved

Uniphar plc

Headquartered in Dublin, Uniphar is an Irish-incorporated public limited company traded on Euronext Dublin and the London Stock Exchange. It is an international diversified healthcare services business, servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three sectors/divisions - commercial & clinical, product access and supply chain & retail.

 

LXV Remedies Holdings Limited

LXV Remedies is the ultimate parent company of Sam McCauley Chemists Limited. Sam McCauley owns and operates a group of 37 retail pharmacies located across Leinster, Munster and Ulster. All of the 37 pharmacies trade under the name McCauley Health & Beauty Pharmacy.

Contacts
View all mergers

Sign up for the latest news from CCPC